NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Effects of Omega-3 Fatty Acids on Cognitive Function with Aging, Dementia, and Neurological Diseases
Evidence Reports/Technology Assessments, No. 114
Catherine H MacLean, MD, PhD, Task Order Director, Amalia M Issa, MPH, PhD, Scientific Reviewer, Sydne J Newberry, PhD, Editor, Walter A Mojica, MD, MPH, Scientific Reviewer, Sally C Morton, PhD, Program Director, Rena Hasenfeld Garland, BA, Project Manager, Lara G Hilton, BA, Programmer/Analyst, Shana Traina, MA, Staff Assistant, and Paul G Shekelle, MD, PhD, Program Director.
Structured Abstract
Context:
It has been suggested that omega 3-fatty acids have beneficial effects in several conditions and disorders affecting the central nervous system, including providing a protective effect on cognitive function with aging; dementia, particularly senile dementia of the Alzheimer's type; multiple sclerosis and some of the peroxisomal biogenesis disorders.
Objectives:
To assess the effect of omega-3 fatty acids on 1) cognitive function in normal aging 2) the incidence of dementia, 3) treatment of dementia, 4) the incidence of several neurological diseases, and 5) clinical outcomes related to the progression of multiple sclerosis.
Data Sources:
We searched computerized databases to identify potentially relevant studies and contacted industry experts for unpublished data.
Study Selection:
We screened 5,865 titles, reviewed 497 studies - of which 62 underwent a detailed review, and found 12 studies that pertained to our objectives. We included controlled clinical trials and observational studies, including prospective cohort, case-control, and case series designs; we excluded case reports. We had no language restrictions.
Data Extraction:
We abstracted data on the effects of omega-3 fatty acids and on study design; relevant outcomes; study population; source, type, amount, and duration of omega-3 fatty acid consumption; and parameters of methodologic quality.
Data Synthesis:
1) A single cohort study has assessed the effects of omega-3 fatty acids on cognitive function with normal aging and found no association for fish or total omega-3 consumption. 2 and 3) In four studies (3 prospective cohort studies and one RCT) that assessed the effects of omega-3 fatty acids on incidence and treatment of dementia, a trend in favor of omega-3 fatty acids (fish and total omega-3 consumption) toward reducing risk of dementia and improving cognitive function was reported. 4) Two studies, one cohort and one case-control, that assessed the effects of omega-3 fatty acids on incidence of MS were inconclusive. A single cohort study evaluating the effects of omega-3 fatty acids on incidence of Parkinson's disease found no significant association between dietary intake of omega 3 fatty acids (fish, ALA, EPA, or DHA) and Parkinson's. Another single case-control study found a significant association between maternal fish consumption at least once a week throughout pregnancy and a lower risk of cerebral palsy in offspring. 5) In one RCT, omega-3 fatty acids (fish, ALA, EPA, DHA) had no effect on the progression of multiple sclerosis; two single-arm open-label trials showed improvement in disability with omega-3 supplementation.
Conclusions:
The quantity and strength of evidence for effects of omega-3 fatty acids on the neurological conditions assessed vary greatly. Due to the small number of studies that met our inclusion criteria, further research is necessary before substantive conclusions can be drawn. The paucity of evidence in this area suggests that a great deal of epidemiological and clinical research remains to be done before any conclusions can be drawn or policy recommendations can be made regarding the health effects of omega-3 fatty acids on normal cognitive function with aging, dementia, and neurological diseases.
Contents
Librarians: Jessie McGowan, MLIS; Nancy Santesso, RD, MLIS. Staff Assistants: Shannon Rhodes, MFA; Cony Rolon, BA.
Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.1 Contract No. 290-02-0003. Prepared by: Southern California/RAND Evidence-based Practice Center, Los Angeles, CA.
Suggested citation:
MacLean CH, Issa AM, Newberry SJ, Mojica WA, Morton SC, Garland RH, Hilton LG, Traina SB, Shekelle PG. Effects of Omega-3 Fatty Acids on Cognitive Function with Aging, Dementia, and Neurological Diseases. Evidence Report/Technology Assessment No. 114 (Prepared by the Southern California Evidence-based Practice Center, under Contract No. 290-02-0003.) AHRQ Publication No. 05-E011-2. Rockville, MD. Agency for Healthcare Research and Quality. February 2005.
This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
AHRQ is the lead Federal agency charged with supporting research designed to improve the quality of health care, reduce its cost, address patient safety and medical errors, and broaden access to essential services. AHRQ sponsors and conducts research that provides evidence-based information on health care outcomes; quality; and cost, use, and access. The information helps health care decisionmakers—patients and clinicians, health system leaders, and policymakers—make more informed decisions and improve the quality of health care services.
The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services of a particular drug, device, test, treatment, or other clinical service.
- 1
540 Gaither Road, Rockville, MD 20850. www
.ahrq.gov
- Review Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview.[Prog Neuropsychopharmacol Biol...]Review Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview.Mazza M, Pomponi M, Janiri L, Bria P, Mazza S. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30; 31(1):12-26. Epub 2006 Aug 28.
- Review [Omega-3 fatty acids and cognition].[Nihon Rinsho. 2014]Review [Omega-3 fatty acids and cognition].Hashimoto M. Nihon Rinsho. 2014 Apr; 72(4):648-56.
- Review Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association.[Nat Clin Pract Neurol. 2009]Review Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association.Fotuhi M, Mohassel P, Yaffe K. Nat Clin Pract Neurol. 2009 Mar; 5(3):140-52.
- Review [Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited].[Lakartidningen. 2007]Review [Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited].Palmblad J, Eriksdotter-Jönhagen M, Freund-Levi Y, Cederholm T. Lakartidningen. 2007 Oct 31-Nov 6; 104(44):3268-71.
- Review The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: a systematic review.[Dement Geriatr Cogn Disord. 2006]Review The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: a systematic review.Issa AM, Mojica WA, Morton SC, Traina S, Newberry SJ, Hilton LG, Garland RH, Maclean CH. Dement Geriatr Cogn Disord. 2006; 21(2):88-96. Epub 2005 Dec 9.
- Effects of Omega-3 Fatty Acids on Cognitive Function with Aging, Dementia, and N...Effects of Omega-3 Fatty Acids on Cognitive Function with Aging, Dementia, and Neurological Diseases
Your browsing activity is empty.
Activity recording is turned off.
See more...